Topical Lidocaine for Chronic Pain Treatment

References

• BrennanMJ. The effect of opioid therapy on endocrine function. Am J Med. 2013;126(3 Suppl 1):S12–18. doi:10.1016/j.amjmed.2012.12.00123414717
   PubMed Web of Science ®Google Scholar
• CohenSP, MaoJ. Neuropathic pain: mechanisms and their clinical implications. BMJ. 2014;348:f7656. doi:10.1136/bmj.f765624500412
   PubMed Web of Science ®Google Scholar
• DworkinRH, O’ConnorAB, AudetteJ, et al. Recommendations for the pharmacological management of neuropathic pain: an overview and literature update. Mayo Clin Proc. 2010;85(3 Suppl):S3–14. doi:10.4065/mcp.2009.0649
   PubMed Web of Science ®Google Scholar
• FinnerupNB, AttalN, HaroutounianS, et al. Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis. Lancet Neurol. 2015;14(2):162–173. doi:10.1016/S1474-4422(14)70251-025575710
   PubMed Web of Science ®Google Scholar
• Centre for Clinical Practice at NICE (UK). Neuropathic pain: the pharmacological management of neuropathic pain in adults in non-specialist settings. UK: National Institute for Health and Care Excellence; 2013. Available from: http://www.ncbi.nlm.nih.gov/books/NBK266257/. Accessed 415, 2021.
   Google Scholar
• MoissetX, BouhassiraD, Avez CouturierJ, et al. Pharmacological and non-pharmacological treatments for neuropathic pain: systematic review and French recommendations. Rev Neurol (Paris). 2020;176(5):325–352. doi:10.1016/j.neurol.2020.01.36132276788
   PubMed Web of Science ®Google Scholar
• DengY, LuoL, HuY, FangK, LiuJ. Clinical practice guidelines for the management of neuropathic pain: a systematic review. BMC Anesthesiol. 2016;16(1):12. doi:10.1186/s12871-015-0150-526892406
   PubMed Web of Science ®Google Scholar
• PickeringG, MarcouxM, ChapiroS, et al. An algorithm for neuropathic pain management in older people. Drugs Aging. 2016;33(8):575–583. doi:10.1007/s40266-016-0389-727510615
   PubMed Web of Science ®Google Scholar
• de León-CasasolaOA, MayoralV. The topical 5% lidocaine medicated plaster in localized neuropathic pain: a reappraisal of the clinical evidence. J Pain Res. 2016;9:67–79. doi:10.2147/JPR.S9923126929664
   PubMed Web of Science ®Google Scholar
• GordhT, GordhTE, LindqvistK, WarnerDS. Lidocaine: the origin of a modern local anesthetic 1949. Anesthesiology. 2010;113(6):1433–1437. doi:10.1097/ALN.0b013e3181fcef4821068652
   PubMed Web of Science ®Google Scholar
• LIDODERM patch prescribing information. Malvern PA: Endo Pharmaceuticals Inc; 2015. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020612s012lbl.pdf. Accessed 415, 2021.
   Google Scholar
• Versatis 700mg medicated plaster - summary of product characteristics (SmPC) - (emc). Available from: https://www.medicines.org.uk/emc/product/290/smpc#gref. Accessed 415, 2021.
   Google Scholar
• GammaitoniAR, AlvarezNA, GalerBS. Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol. 2003;43(2):111–117. doi:10.1177/009127000223981712616661
   PubMed Web of Science ®Google Scholar
• HermannsH, HollmannMW, StevensMF, et al. Molecular mechanisms of action of systemic lidocaine in acute and chronic pain: a narrative review. Br J Anaesth. 2019;123(3):335–349. doi:10.1016/j.bja.2019.06.01431303268
   PubMed Web of Science ®Google Scholar
• MeierT, WasnerG, FaustM, et al. Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: a randomized, double-blind, placebo-controlled study. Pain. 2003;106(1–2):151–158. doi:10.1016/s0304-3959(03)00317-814581122
   PubMed Web of Science ®Google Scholar
• RehmS, BinderA, BaronR. Post-herpetic neuralgia: 5% lidocaine medicated plaster, pregabalin, or a combination of both? A randomized, open, clinical effectiveness study. Curr Med Res Opin. 2010;26(7):1607–1619. doi:10.1185/03007995.2010.48367520429825
   PubMed Web of Science ®Google Scholar
• PickeringG, VouteM, MacianN, GanryH, PereiraB. Effectiveness and safety of 5% lidocaine-medicated plaster on localized neuropathic pain after knee surgery: a randomized, double-blind controlled trial. Pain. 2019;160(5):1186–1195. doi:10.1097/j.pain.000000000000150231009419
   PubMed Web of Science ®Google Scholar
• BaronR, BinderA, AttalN, CasaleR, DickensonAH, TreedeR-D. Neuropathic low back pain in clinical practice. Eur J Pain. 2016;20(6):861–873. doi:10.1002/ejp.83826935254
   PubMed Web of Science ®Google Scholar
• BuksnysT, ArmstrongN, WorthyG, et al. Systematic review and network meta-analysis of the efficacy and safety of lidocaine 700 mg medicated plaster vs. pregabalin. Curr Med Res Opin. 2020;36(1):101–115. doi:10.1080/03007995.2019.166268731469302
   PubMed Web of Science ®Google Scholar
• DerryS, WiffenPJ, MooreRA, QuinlanJ. Topical lidocaine for neuropathic pain in adults. Cochrane Database Syst Rev. 2014;(7):CD010958. doi:10.1002/14651858.CD010958.pub225058164
   PubMed Web of Science ®Google Scholar
• DerryS, WiffenPJ, KalsoEA, et al. Topical analgesics for acute and chronic pain in adults - an overview of Cochrane reviews. Cochrane Database Syst Rev. 2017;5:CD008609. doi:10.1002/14651858.CD008609.pub228497473
   PubMed Web of Science ®Google Scholar
• DemantDT, LundK, FinnerupNB, et al. Pain relief with lidocaine 5% patch in localized peripheral neuropathic pain in relation to pain phenotype: a randomised, double-blind, and placebo-controlled, phenotype panel study. Pain. 2015;156(11):2234–2244. doi:10.1097/j.pain.000000000000026626090758
   PubMed Web of Science ®Google Scholar
• HoK-Y, HuhBK, WhiteWD, Yeh-C-C, MillerEJ. Topical amitriptyline versus lidocaine in the treatment of neuropathic pain. Clin J Pain. 2008;24(1):51–55. doi:10.1097/AJP.0b013e318156db2618180637
   PubMed Web of Science ®Google Scholar
• WhiteWT, PatelN, DrassM, NalamachuS. Lidocaine patch 5% with systemic analgesics such as gabapentin: a rational polypharmacy approach for the treatment of chronic pain. Pain Med. 2003;4(4):321–330. doi:10.1111/j.1526-4637.2003.03045.x14750908
   PubMed Web of Science ®Google Scholar
• van HeckeO, AustinSK, KhanRA, SmithBH, TorranceN. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 2014;155(4):654–662. doi:10.1016/j.pain.2013.11.01324291734
   PubMed Web of Science ®Google Scholar
• TreedeR-D, JensenTS, CampbellJN, et al. Neuropathic pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008;70(18):1630–1635. doi:10.1212/01.wnl.0000282763.29778.5918003941
   PubMed Web of Science ®Google Scholar
• BinderA, BruxelleJ, RogersP, HansG, BöslI, BaronR. Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trial. Clin Drug Investig. 2009;29(6):393–408. doi:10.2165/00044011-200929060-00003
   PubMed Web of Science ®Google Scholar
• BaronR, MayoralV, LeijonG, BinderA, SteigerwaldI, SerpellM. 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT Study. Curr Med Res Opin. 2009;25(7):1663–1676. doi:10.1185/0300799090304788019485723
   PubMed Web of Science ®Google Scholar
• SonohataM, TsurutaT, MineH, et al. Clinical characteristics of neuropathic pain in patients with carpal tunnel syndrome. Hand Surg. 2014;19(1):43–48. doi:10.1142/S021881041450008724641740
   PubMedGoogle Scholar
• ChevilleAL, SloanJA, NorthfeltDW, et al. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a Phase III double-blind crossover study (N01CB). Support Care Cancer. 2009;17(4):451–460. doi:10.1007/s00520-008-0542-x19142669
   PubMed Web of Science ®Google Scholar
• FornasariD. Pharmacotherapy for neuropathic pain: a review. Pain Ther. 2017;6(Suppl 1):25–33. doi:10.1007/s40122-017-0091-429178034
   PubMed Web of Science ®Google Scholar
• DualéC, OuchchaneL, SchoefflerP, DubrayC; EDONIS Investigating Group. Neuropathic aspects of persistent postsurgical pain: a French multicenter survey with a 6-month prospective follow-up. J Pain. 2014;15(1):24.e1–24.e20. doi:10.1016/j.jpain.2013.08.014
   Google Scholar
• AmmitzbøllG, AndersenKG, BidstrupPE, et al. Effect of progressive resistance training on persistent pain after axillary dissection in breast cancer: a randomized controlled trial. Breast Cancer Res Treat. 2020;179(1):173–183. doi:10.1007/s10549-019-05461-z31605312
   PubMed Web of Science ®Google Scholar
• DualéC, GuastellaV, MorandD, et al. Characteristics of the neuropathy induced by thoracotomy: a 4-month follow-up study with psychophysical examination. Clin J Pain. 2011;27(6):471–480. doi:10.1097/AJP.0b013e31820e12d421368665
   PubMed Web of Science ®Google Scholar
• AasvangEK, GmaehleE, HansenJB, et al. Predictive risk factors for persistent postherniotomy pain. Anesthesiology. 2010;112(4):957–969. doi:10.1097/ALN.0b013e3181d31ff820234307
   PubMed Web of Science ®Google Scholar
• Wilder-SmithCH, HillLT, LaurentS. Postamputation pain and sensory changes in treatment-naive patients: characteristics and responses to treatment with tramadol, amitriptyline, and placebo. Anesthesiology. 2005;103(3):619–628. doi:10.1097/00000542-200509000-0002716129989
   PubMed Web of Science ®Google Scholar
• PalladiniM, BoeslI, KoenigS, BuchheisterB, AttalN. Lidocaine medicated plaster, an additional potential treatment option for localized post-surgical neuropathic pain: efficacy and safety results of a randomized, placebo-controlled trial. Curr Med Res Opin. 2019;35(5):757–766. doi:10.1080/03007995.2019.156570930614286
   PubMed Web of Science ®Google Scholar
• SansoneP, PassavantiMB, FiorelliA, et al. Efficacy of the topical 5% lidocaine medicated plaster in the treatment of chronic post-thoracotomy neuropathic pain. Pain Manag. 2017;7(3):189–196. doi:10.2217/pmt-2016-006028326950
   PubMed Web of Science ®Google Scholar
• BischoffJM, PetersenM, UçeylerN, SommerC, KehletH, WernerMU. Lidocaine patch (5%) in treatment of persistent inguinal postherniorrhaphy pain: a randomized, double-blind, placebo-controlled, crossover trial. Anesthesiology. 2013;119(6):1444–1452. doi:10.1097/ALN.0b013e3182a2a24323887198
   PubMed Web of Science ®Google Scholar
• Correa-IllanesG, RoaR, PiñerosJL, CalderónW. Use of 5% lidocaine medicated plaster to treat localized neuropathic pain secondary to traumatic injury of peripheral nerves. Local Reg Anesth. 2012;5:47–53. doi:10.2147/LRA.S3186823152700
   PubMedGoogle Scholar
• KanaiA, SegawaY, OkamotoT, KotoM, OkamotoH. The analgesic effect of a metered-dose 8% lidocaine pump spray in posttraumatic peripheral neuropathy: a pilot study. Anesth Analg. 2009;108(3):987–991. doi:10.1213/ane.0b013e31819431aa19224814
   PubMed Web of Science ®Google Scholar
• KanaiA, OkamotoT, SuzukiK, NikiY, OkamotoH. Lidocaine eye drops attenuate pain associated with ophthalmic postherpetic neuralgia. Anesth Analg. 2010;110(5):1457–1460. doi:10.1213/ANE.0b013e3181d5adaf20237042
   PubMed Web of Science ®Google Scholar
• RowbothamMC, DaviesPS, FieldsHL. Topical lidocaine gel relieves postherpetic neuralgia. Ann Neurol. 1995;37(2):246–253. doi:10.1002/ana.4103702167847866
   PubMed Web of Science ®Google Scholar
• RowbothamMC, DaviesPS, VerkempinckC, GalerBS. Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain. 1996;65(1):39–44. doi:10.1016/0304-3959(95)00146-88826488
   PubMed Web of Science ®Google Scholar
• LinP-L, FanS-Z, HuangC-H, et al. Analgesic effect of lidocaine patch 5% in the treatment of acute herpes zoster: a Double-Blind and Vehicle-Controlled Study. Reg Anesth Pain Med. 2008;33(4):320–325. doi:10.1016/j.rapm.2007.02.01518675742
   PubMed Web of Science ®Google Scholar
• GalerBS, RowbothamMC, PeranderJ, FriedmanE. Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an Enriched Enrollment Study. Pain. 1999;80(3):533–538. doi:10.1016/S0304-3959(98)00244-910342414
   PubMed Web of Science ®Google Scholar
• GalerBS, JensenMP, MaT, DaviesPS, RowbothamMC. The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain. 2002;18(5):297–301. doi:10.1097/00002508-200209000-0000412218500
   PubMed Web of Science ®Google Scholar
• LiuX, WeiL, ZengQ, LinK, ZhangJ. The treatment of topical drugs for postherpetic neuralgia: a network meta-analysis. Pain Physician. 2020;23(6):541–551.33185370
   PubMed Web of Science ®Google Scholar
• WolffRF, BalaMM, WestwoodM, KesselsAG, KleijnenJ. 5% lidocaine-medicated plaster vs other relevant interventions and placebo for post-herpetic neuralgia (PHN): a systematic review. Acta Neurol Scand. 2011;123(5):295–309. doi:10.1111/j.1600-0404.2010.01433.x21039364
   PubMed Web of Science ®Google Scholar
• KhaliqW, AlamS, PuriN. Topical lidocaine for the treatment of postherpetic neuralgia. Cochrane Database Syst Rev. 2007;2:CD004846. doi:10.1002/14651858.CD004846.pub2
   Web of Science ®Google Scholar
• SabatowskiR, HansG, TackenI, KapanadzeS, BuchheisterB, BaronR. Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgia. Curr Med Res Opin. 2012;28(8):1337–1346. doi:10.1185/03007995.2012.70797722769236
   PubMed Web of Science ®Google Scholar
• HansG, SabatowskiR, BinderA, BoeslI, RogersP, BaronR. Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: results of a long-term study. Curr Med Res Opin. 2009;25(5):1295–1305. doi:10.1185/0300799090290136819366301
   PubMed Web of Science ®Google Scholar
• ArgoffCE, GalerBS, JensenMP, OlekaN, GammaitoniAR. Effectiveness of the lidocaine patch 5% on pain qualities in three chronic pain states: assessment with the neuropathic pain scale. Curr Med Res Opin. 2004;20(Suppl 2):S21–28. doi:10.1185/030079904X1296015563743
   PubMed Web of Science ®Google Scholar
• SnedecorSJ, SudharshanL, CappelleriJC, SadoskyA, MehtaS, BottemanM. Systematic review and meta-analysis of pharmacological therapies for painful diabetic peripheral neuropathy. Pain Pract. 2014;14(2):167–184. doi:10.1111/papr.1205423534696
   PubMed Web of Science ®Google Scholar
• WolffRF, BalaMM, WestwoodM, KesselsAG, KleijnenJ. 5% Lidocaine medicated plaster in painful diabetic peripheral neuropathy (DPN): a systematic review. Swiss Med Wkly. 2010;140(21–22):297–306.20458651
   PubMed Web of Science ®Google Scholar
• BarbanoRL, HerrmannDN, Hart-GouleauS, Pennella-VaughanJ, LodewickPA, DworkinRH. Effectiveness, tolerability, and impact on quality of life of the 5% lidocaine patch in diabetic polyneuropathy. Arch Neurol. 2004;61(6):914–918. doi:10.1001/archneur.61.6.91415210530
   PubMedGoogle Scholar
• NalamachuS, CrockettRS, MathurD. Lidocaine patch 5 for carpal tunnel syndrome: how it compares with injections: a Pilot Study. J Fam Pract. 2006;55(3):209–214.16510054
   PubMed Web of Science ®Google Scholar
• NalamachuS, CrockettRS, GammaitoniAR, GouldEM. A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: a 6-Week, Randomized, Parallel-Group Study. MedGenMed. 2006;8(3):33.
   Google Scholar
• MoghtaderiAR, JazayeriSM, AziziS. EMLA cream for carpal tunnel syndrome: how it compares with steroid injection. Electromyogr Clin Neurophysiol. 2009;49(6–7):287–289.19845100
   PubMedGoogle Scholar
• HochbergMC, AltmanRD, AprilKT, et al. American college of rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care Res (Hoboken). 2012;64(4):465–474. doi:10.1002/acr.2159622563589
   PubMed Web of Science ®Google Scholar
• KamperSJ, ApeldoornAT, ChiarottoA, et al. Multidisciplinary biopsychosocial rehabilitation for chronic low back pain. Cochrane Database Syst Rev. 2014;9:CD000963. doi:10.1002/14651858.CD000963.pub3
   PubMed Web of Science ®Google Scholar
• BeaudartC, BiverE, BruyèreO, et al. Quality of life assessment in musculo-skeletal health. Aging Clin Exp Res. 2018;30(5):413–418. doi:10.1007/s40520-017-0794-828664458
   PubMed Web of Science ®Google Scholar
• VitaloniM, Botto-van BemdenA, Sciortino ContrerasRM, et al. Global management of patients with knee osteoarthritis begins with quality of life assessment: a systematic review. BMC Musculoskelet Disord. 2019;20(1):493. doi:10.1186/s12891-019-2895-331656197
   PubMed Web of Science ®Google Scholar
• BeckerA, HeldH, RedaelliM, et al. Low back pain in primary care: costs of care and prediction of future health care utilization. Spine. 2010;35(18):1714–1720. doi:10.1097/brs.0b013e3181cd656f21374895
   PubMed Web of Science ®Google Scholar
• HestbaekL, Leboeuf-YdeC, MannicheC. Low back pain: what is the long-term course? A review of studies of general patient populations. Eur Spine J. 2003;12(2):149–165. doi:10.1007/s00586-002-0508-512709853
   PubMed Web of Science ®Google Scholar
• HashmiJA, BalikiMN, HuangL, et al. Lidocaine patch (5%) is no more potent than placebo in treating chronic back pain when tested in a randomised double blind placebo controlled brain imaging study. Mol Pain. 2012;8:29. doi:10.1186/1744-8069-8-2922531485
   PubMed Web of Science ®Google Scholar
• CastroE, DentD. A comparison of transdermal over-the-counter lidocaine 3.6% menthol 1.25%, Rx lidocaine 5% and placebo for back pain and arthritis. Pain Manag. 2017;7(6):489–498. doi:10.2217/pmt-2017-002928805147
   PubMed Web of Science ®Google Scholar
• BalikiMN, GehaPY, JabakhanjiR, HardenN, SchnitzerTJ, ApkarianAV. A preliminary fMRI study of analgesic treatment in chronic back pain and knee osteoarthritis. Mol Pain. 2008;4:47. doi:10.1186/1744-8069-4-4718950528
   PubMed Web of Science ®Google Scholar
• GimbelJ, LinnR, HaleM, NicholsonB. Lidocaine patch treatment in patients with low back pain: results of an open-label, nonrandomized pilot study. Am J Ther. 2005;12(4):311–319. doi:10.1097/01.mjt.0000164828.57392.ba16041194
   PubMedGoogle Scholar
• KivitzA, FairfaxM, SheldonEA, et al. Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults. Clin Ther. 2008;30(12):2366–2377. doi:10.1016/j.clinthera.2008.12.01519167595
   PubMed Web of Science ®Google Scholar
• BurchF, CoddingC, PatelN, SheldonE. Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients. A prospective, multicenter, open-label effectiveness trial. Osteoarthritis Cartilage. 2004;12(3):253–255. doi:10.1016/j.joca.2003.10.00714972343
   PubMed Web of Science ®Google Scholar
• GalerBS, GammaitoniAR, OlekaN, JensenMP, ArgoffCE. Use of the lidocaine patch 5% in reducing intensity of various pain qualities reported by patients with low-back pain. Curr Med Res Opin. 2004;20(Suppl 2):S5–12. doi:10.1185/030079904X12933
   PubMed Web of Science ®Google Scholar
• GammaitoniAR, GalerBS, OnawolaR, JensenMP, ArgoffCE. Lidocaine patch 5% and its positive impact on pain qualities in osteoarthritis: results of a pilot 2-week, open-label study using the Neuropathic Pain Scale. Curr Med Res Opin. 2004;20(Suppl 2):S13–19. doi:10.1185/030079904X1295115563742
   PubMed Web of Science ®Google Scholar
• Scilex presents ZTlidoTM data on superior adhesion over lidocaine patch formulation. SCILEX Pharmaceutical; 97, 2018. Available from: https://www.scilexpharma.com/press-release/scilex-presents-ztlido-data-on-superior-adhesion-over-lidocaine-patch-formulation/. Accessed 415, 2021.
   Google Scholar
• GudinJ, FudinJ, WangE, HaylonT, PatelK, GossTF. Treatment patterns and medication use in patients with postherpetic neuralgia. J Manag Care Spec Pharm. 2019;25(12):1387–1396. doi:10.18553/jmcp.2019.1909331589557
   PubMed Web of Science ®Google Scholar
• MooreRA, Chi-C-C, WiffenPJ, DerryS, RiceASC. Oral nonsteroidal anti-inflammatory drugs for neuropathic pain. Cochrane Database Syst Rev. 2015;(10):CD010902. doi:10.1002/14651858.CD010902.pub226436601
   PubMed Web of Science ®Google Scholar
• SnyderMJ, GibbsLM, LindsayTJ. Treating painful diabetic peripheral neuropathy: an update. Am Fam Physician. 2016;94(3):227–234.27479625
   PubMed Web of Science ®Google Scholar
• YangX-D, FangP-F, XiangD-X, Yang-Y-Y. Topical treatments for diabetic neuropathic pain. Exp Ther Med. 2019;17(3):1963–1976. doi:10.3892/etm.2019.717330783472
   PubMed Web of Science ®Google Scholar
• StanosSP, GalluzziKE. Topical therapies in the management of chronic pain. Postgrad Med. 2013;125(4 Suppl 1):25–33. doi:10.1080/00325481.2013.111056711124547601
   PubMedGoogle Scholar
• BarkinRL. The pharmacology of topical analgesics. Postgrad Med. 2013;125(4 Suppl 1):7–18. doi:10.1080/00325481.2013.1110566911
   PubMedGoogle Scholar
• PickeringG. Antiepileptics for post-herpetic neuralgia in the elderly: current and future prospects. Drugs Aging. 2014;31(9):653–660. doi:10.1007/s40266-014-0202-425178422
   PubMed Web of Science ®Google Scholar
• PickeringG, MartinE, TiberghienF, DelormeC, MickG. Localized neuropathic pain: an expert consensus on local treatments. Drug Des Devel Ther. 2017;11:2709–2718. doi:10.2147/DDDT.S142630
   PubMed Web of Science ®Google Scholar
• SawynokJ. Topical analgesics for neuropathic pain: preclinical exploration, clinical validation, future development. Eur J Pain. 2014;18(4):465–481. doi:10.1002/j.1532-2149.2013.00400.x24108446
   PubMed Web of Science ®Google Scholar
• Topical-medications-in-the-treatment-of-pain.pdf. Available from: http://www.nationalsalesforce.org/wp-content/uploads/2014/08/Topical-Medications-in-the-Treatment-of-Pain.pdf. Accessed 415, 2021.
   Google Scholar
• WolfeGI, BarohnRJ. Painful peripheral neuropathy. Curr Treat Options Neurol. 2002;4(3):177–188. doi:10.1007/s11940-002-0034-011931724
   PubMedGoogle Scholar
• FrostSG. Treatment of complex regional pain syndrome type 1 in a pediatric patient using the lidocaine patch 5%: a case report. Curr Ther Res Clin Exp. 2003;64(8):626–629. doi:10.1016/j.curtheres.2003.09.01024944409
   PubMed Web of Science ®Google Scholar
• NayakS, CunliffeM. Lidocaine 5% patch for localized chronic neuropathic pain in adolescents: report of five cases. Paediatr Anaesth. 2008;18(6):554–558. doi:10.1111/j.1460-9592.2008.02491.x18363625
   PubMed Web of Science ®Google Scholar
• RasolofoJ, PonceletM, RousseauV, Marec-BerardP. [Analgesic efficacy of topical lidocaine for vaso-occlusive crisis in children with sickle cell disease]. Arch Pediatr. 2013;20(7):762–767. French. doi:10.1016/j.arcped.2013.04.01323731603
   PubMed Web of Science ®Google Scholar
• FriedrichsdorfSJ, NugentAP. Management of neuropathic pain in children with cancer. Curr Opin Support Palliat Care. 2013;7(2):131–138. doi:10.1097/SPC.0b013e3283615ebe23635878
   PubMed Web of Science ®Google Scholar
• GoddardJM, ReaneyRL. Lidocaine 5%-medicated plaster (Versatis) for localised neuropathic pain: results of a multicentre evaluation of use in children and adolescents. Br J Pain. 2018;12(3):189–193. doi:10.1177/204946371875643130057764
   PubMed Web of Science ®Google Scholar
• FitzgeraldM. The development of nociceptive circuits. Nat Rev Neurosci. 2005;6(7):507–520. doi:10.1038/nrn170115995722
   PubMed Web of Science ®Google Scholar
• JorgeLL, FeresCC, TelesVE. Topical preparations for pain relief: efficacy and patient adherence. J Pain Res. 2010;4:11–24. doi:10.2147/JPR.S949221386951
   PubMedGoogle Scholar
• Lidocaine (Topical Application Route).  Available from: https://www.mayoclinic.org/drugs-supplements/lido865caine-topical-application-route/proper-use/drg-2007277. Accessed September 21, 2021.
   Google Scholar